latest blog entries
Loading...
Branding...
latest headlines for company on cafepharma
Seeking Alpha
Tue, 04/16/13 - 11:55 am
tags: AbbVie, Achillion, Bristol-Myers Squibb, Gilead, Idenix, Merck, sofosbuvir
Motley Fool
Wed, 02/27/13 - 12:24 pm
Motley Fool
Sat, 01/12/13 - 11:38 am
Motley Fool
Sun, 12/30/12 - 1:15 pm
tags: Abbott Laboratories, Achillion, Gilead Sciences, GSK, HCV, hepatitis C, Idenix, JNJ, Merck, Vertex Pharmaceuticals
Motley Fool
Fri, 12/28/12 - 12:36 pm
tags: Abbott Labs, Achillion, Bristol-Myers Squibb, Gilead, GSK, hepatitis C, Idenix, JNJ, Merck, Vertex Pharmaceuticals
Seeking Alpha
Fri, 11/30/12 - 1:10 pm
tags: Achillion, Gilead, hepatitis C, Idenix, Medivir, Merck, Vertex Pharmaceuticals
Motley Fool
Sat, 11/24/12 - 1:01 pm
Motley Fool
Sat, 11/17/12 - 2:47 pm
Motley Fool
Tue, 11/13/12 - 12:51 pm
Motley Fool
Sat, 11/10/12 - 9:19 am
Motley Fool
Sat, 11/03/12 - 11:28 am
Last 30 twitter posts
-
$IDIX $4.41 keep the uptrend, very close to fill the gap as well @ $4.55 .. great pick @ $3.52 since @JasonCRG report t.co/0rHWbaEpji
-
Idenix Pharmaceuticals' CEO Presents at UBS Global Healthcare Services Conference Transcript t.co/vl1FzuHF2P
-
Idenix Pharmaceuticals' CEO Presents at UBS Global Healthcare Services Conference (Transcript) t.co/9JT4VOuyMt #biotech
-
Idenix Pharmaceuticals' CEO Presents at UBS Global Healthcare Services Conference (Transcript): [at Seeking Al... t.co/s4jXYff78S
-
BioTweet - Idenix Pharmaceuticals' CEO Presents at UBS Global Healthcare Services Conference... t.co/3FCvDChmR1 via @SeekingAlpha
-
$IDIX - Idenix Pharmaceuticals Inc. #BUY Signal, #Bullish #stocks #investing
-
Biotech Top Gainers, Halozyme Therapeutics, TESARO, Puma Biotechnology ...: Shares of Halozyme Therapeutics, I... t.co/94XJw8uKFH
Latest Health Message Board Posts
... of Inhibitex Inc. after one patient died and others were hospitalized while taking the drug in a study. This week, Idenix Pharmaceuticals Inc. said U.S. regulators halted its study of a similar therapy, marking the second hold on clinical trials for the ...
Posted by:
veteranB
at
2012-10-22 05:00:00
on
medhelp.org
... potential hepatitis C drug after nine participants in a clinical trial of the therapy were hospitalized and one died.' 'Idenix Pharmaceuticals, based in Cambridge, Massachusetts, had a drug in trial that acted with a mechanism similar to that of BMS-986094 ...
Posted by:
veteranB
at
2012-10-20 05:00:00
on
medhelp.org
... ://www.nytimes.com/2012/08/03/business/bristol-myers-to-suspend-hepatitis-c-drug-study.html?_r=1 also: http://news.yahoo.com/idenix-hepatitis-c-drug-put-partial-hold-122057468--finance.html and:http://www.forbes.com/sites/melaniehaiken/2012/08/16/are-you ...
Posted by:
rpooo
at
2012-10-06 05:00:00
on
medhelp.org
... drug was on hold for a long time because of concerns about the effects of the drug on the liver and now they want Idenix to provide results from ECG tests on 67 patients who were in the trial? Oh, and I did not know that Nucleotide polymerase inhibitors ...
Posted by:
HectorSF
at
2012-09-12 05:00:00
on
medhelp.org
... with oral protease inhibitor ABT-450/r (ABT-450 and ritonavir). (See BioWorld Today, Dec. 13, 2006, and Oct. 14, 2011.) Idenix is awaiting the FDA's decision to lift a partial clinical hold on its oral nuc IDX184 after interim Phase IIb data showed it was ...
Posted by:
jules2551
at
2012-08-27 05:00:00
on
medhelp.org
... From the FDA for the Treatment of Chronic Hepatitis C Infection CAMBRIDGE, Mass., July 25, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment ...
Posted by:
jules2551
at
2012-08-24 05:00:00
on
medhelp.org
... stopped development of its treatment, known informally as 094, after one patient died in testing and eight others were hospitalized. Idenix said that no patients have been exposed to IDX19368. President and Chief Executive Ron Renaud also said that while ...
Posted by:
jerialice
at
2012-08-17 05:00:00
on
medhelp.org
... drug, said Megan Pace, a company spokeswoman. “Our drug is structurally different” than those from Bristol-Myers and Idenix, Pace said in a telephone interview. “We’re moving forward with our studies.” Bristol-Myers gained the compound in January with ...
Posted by:
Idyllic
at
2012-08-17 05:00:00
on
medhelp.org
... Big Three already mentioned. Companies testing therapies, either alone or together, include Achillion Pharmaceuticals Inc. (NASDAQ: ACHN), Idenix Pharmaceuticals Inc. (NASDAQ: IDIX), Merck (NYSE: MRK) and Vertex Pharmaceuticals Inc. (NASDAQ:VRTX). For now ...
Posted by:
orphanedhawk
at
2012-07-31 05:00:00
on
medhelp.org
... Big Three already mentioned. Companies testing therapies, either alone or together, include Achillion Pharmaceuticals Inc. (NASDAQ: ACHN), Idenix Pharmaceuticals Inc. (NASDAQ: IDIX), Merck (NYSE: MRK) and Vertex Pharmaceuticals Inc. (NASDAQ:VRTX). For now ...
Posted by:
willbb
at
2012-07-25 05:00:00
on
medhelp.org